MarketsandMarkets Conferences Blogs
Almost 7 years removed from the first FDA approved Biosimilar (Zarxio) in 2015, the US market for Biosimilars is projected to be highly beneficial over the next decade, for both pharmaceutical companies as well as patients, with RAND Corporation projecting estimated savings of over $54 Billion during this period. To truly comprehend such forecasts, a […]
Graduated from University of Nigeria with a bachelor’s degree in Biomedical Sciences in 1989, Uchenna started her career as a Biomedical Scientist in Nigeria She relocated to the United Kingdom in 1991 where she obtained her Master’s degree in Biomedical Sciences from University of Cardiff with a Distinction in 1996 and went on to score […]
As new drugs are emerging every day, it is very important to ensure that the patients get right and effective treatment. One such step can be taken from Real World Evidence (RWE). In simple words, Real World Evidence means data and information collected outside of a clinical trial. This data can be electronic medical records, […]
